halofuginone hydrobromide

DRUG2 trials

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC, National Cancer Institute (NCI)

Conditions

AIDS-related Kaposi SarcomaRecurrent Kaposi SarcomaUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors

CompletedNCT00027677

European Organisation for Research and Treatment of Cancer - EORTCUnspecified Adult Solid Tumor, Protocol Specific

Start: 2001-08-31Updated: 2012-07-24

Phase 2

Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma

CompletedNCT00064142

National Cancer Institute (NCI)AIDS-related Kaposi Sarcoma, Recurrent Kaposi Sarcoma

Start: 2003-05-31Updated: 2013-06-05